FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.464.1003.1150

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113883.3.464.1003.1150
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.1150/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150
Version20240124
Statusactive
Date2024-01-24T01:11:59-05:00
NameSubstanceUseDisorderShortActingMedication
TitleSubstance Use Disorder Short Acting Medication
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable Acamprosate, Disulfiram, Naltrexone Oral, Buprenorphine Naloxone and Buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm
ValueSet
2.16.840.1.113883.3.464.1003.1259Substance Use Disorder Short Acting Medication

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.1150",
  "meta": {
    "versionId": "12",
    "lastUpdated": "2024-01-24T09:53:01.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-01-24"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.1150"
    }
  ],
  "version": "20240124",
  "name": "SubstanceUseDisorderShortActingMedication",
  "title": "Substance Use Disorder Short Acting Medication",
  "status": "active",
  "date": "2024-01-24T01:11:59-05:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable Acamprosate, Disulfiram, Naltrexone Oral, Buprenorphine Naloxone and Buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:797f7d2c-518b-4ff0-808a-4a629f1a0547",
    "timestamp": "2025-05-23T22:22:43-04:00",
    "total": 21,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1010600",
        "display": "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1010604",
        "display": "buprenorphine 8 MG / naloxone 2 MG Sublingual Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1307056",
        "display": "buprenorphine 4 MG / naloxone 1 MG Sublingual Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1307061",
        "display": "buprenorphine 12 MG / naloxone 3 MG Sublingual Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1431076",
        "display": "buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1431102",
        "display": "buprenorphine 5.7 MG / naloxone 1.4 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1483744",
        "display": "naltrexone hydrochloride 50 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1542390",
        "display": "buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1544851",
        "display": "buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1544854",
        "display": "buprenorphine 6.3 MG / naloxone 1 MG Buccal Film"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1597568",
        "display": "buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1597573",
        "display": "buprenorphine 8.6 MG / naloxone 2.1 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1666338",
        "display": "buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1864412",
        "display": "buprenorphine 0.7 MG / naloxone 0.18 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197623",
        "display": "disulfiram 250 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "197624",
        "display": "disulfiram 500 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "351264",
        "display": "buprenorphine 2 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "351265",
        "display": "buprenorphine 8 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "351266",
        "display": "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "351267",
        "display": "buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "835726",
        "display": "acamprosate calcium 333 MG Delayed Release Oral Tablet"
      }
    ]
  }
}